S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 UpstartPROGRush Street InteractiveWunong Net TechnologyVivos Therapeutics
Price Information
Current Price$65.64$50.00$15.53$11.45$7.51
52 Week RangeHoldBuyBuyN/ABuy
Overall Score1.
Analysis Score2.
Community Score2.
Dividend Score0.
Ownership Score0.
Earnings & Valuation Score1.
Analyst Ratings
Consensus RecommendationHoldBuyBuyN/ABuy
Consensus Price Target$59.33$61.25$27.60N/A$12.00
% Upside from Price Target-9.61% downside22.50% upside77.72% upsideN/A59.79% upside
Trade Information
Market Cap$4.76 billion$3.38 billion$695.64 million$286.25 million$132.68 million
Average Volume1,302,134606,1971,371,5241,453,611205,639
Sales & Book Value
Annual RevenueN/A$3.95 billionN/AN/AN/A
Price / SalesN/A0.86N/AN/AN/A
CashflowN/A$31.45 per shareN/AN/AN/A
Price / CashN/A1.59N/AN/AN/A
Book ValueN/A$26.04 per shareN/AN/AN/A
Price / BookN/A1.92N/AN/AN/A
Net IncomeN/A$31.47 millionN/AN/AN/A
Trailing P/E Ratio0.00N/A0.000.000.00
Forward P/E Ratio596.7314.29
P/E GrowthN/A0.86N/AN/AN/A
Net MarginsN/A-5.00%N/AN/AN/A
Return on Equity (ROE)N/A21.39%N/AN/AN/A
Return on Assets (ROA)N/A11.26%N/AN/AN/A
Annual PayoutN/A$0.18N/AN/AN/A
Dividend YieldN/A0.36%N/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/A4.63%N/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity RatioN/A0.17%N/AN/AN/A
Current RatioN/A3.01%N/AN/AN/A
Quick RatioN/A1.16%N/AN/AN/A
Ownership Information
Institutional Ownership PercentageN/A92.49%51.89%N/AN/A
Insider Ownership PercentageN/A2.78%N/AN/AN/A
Shares Outstanding72.46 million67.56 million44.79 million25.00 million17.67 million
Next Earnings Date3/17/2021 (Confirmed)5/6/2021 (Estimated)3/10/2021 (Confirmed)N/AN/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.